Clinical Trials Directory

Trials / Completed

CompletedNCT04178109

Oral Use of Dexketoprofen/Tramadol for Acute Postoperative Pain in Total Hip Replacement With a Direct Anterior Approach.

EVALUATION OF ORAL USE OF DEXKETOPROFEN/TRAMADOL IN ACUTE POSTOPERATIVE PAIN IN PATIENTS UNDERGOING TOTAL HIP REPLACEMENT WITH A MINIMALLY INVASIVE ANTERIOR APPROACH (AMIS).

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
226 (actual)
Sponsor
KAT General Hospital · Academic / Other
Sex
All
Age
45 Years – 80 Years
Healthy volunteers
Accepted

Summary

Pain is a global public health issue and represents the most common reason for both physician consultation and hospital admissions . When unrelieved or poorly controlled, it is associated with medical complications, poor patient satisfaction and increased risk of developing chronic pain. Dexketoprofen is a new NSAID treating acute postoperative pain and when it combined with tramadol may have a better effect. The purpose of this study is to evaluate the analgesic effect of the oral use of the combination of dexketoprofen/tramadole on the reduction of postoperative pain after total hip arthroplasty with minimal invasive anterior approach (AMIS).

Conditions

Interventions

TypeNameDescription
DRUGDexketoprofen/tramadol (27mg/75mg)Postoperatively patients in Group A received the oral combination dexketoprofen/tramadol for the treatment of acute postoperative pain the first 72h
DRUGTramadol hydrochloridePatients in group B received IV tramadol 75mg every 8h
DRUGParacetamolPatients in group B received IV paracetamol 1g every 8h
DRUGRopivacaine Hydrochloride 7.5 MG/ML300mg ropivacaine as periarticular injection in a dilution of 100ml n/s 0,9% was done by the orthopedic surgeon in all patients
DRUGLevobupivacaine Hydrochloride10-15mg levobupivacaine was done subarachnoidal for spinal anesthesia

Timeline

Start date
2019-01-10
Primary completion
2019-11-10
Completion
2019-11-20
First posted
2019-11-26
Last updated
2019-11-26

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT04178109. Inclusion in this directory is not an endorsement.